Molecules with specificity for CD45 and CD79
US10730952B2 · kind B2 · utility
0Cited by
40References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 16, 2015 |
| Grant date | Aug 4, 2020 |
| Priority date | — |
| Expiry date | Jul 16, 2035 |
Classification
- Technology area (CPC —)General
Abstract
The present disclosure relates to a multispecific molecule comprising a binding domain specific to the antigen CD45 and a binding domain specific to the antigen CD79a and/or CD79b, compositions comprising same and use of each in treatment, for example treatment of autoimmune disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.